Press release
HIV Drug Market to Reach $26,458 Million, Globally by 2022
HIV Drug Market report, published by Allied Market Research, forecasts that the global market is expected to garner $26,458 million by 2022, registering a CAGR of 3.7% during the period 2016 - 2022. The multi-class combination drug segment held over one-third share of the total market in 2015.Read more details @ https://www.alliedmarketresearch.com/hiv-drugs-market
Multi-class combination drugs segment had accounted for more than one-third revenue of the overall HIV drug market in 2015, owing to increase in adoption of combination drugs from this medication class due to their better results in the control of HIV & related coinfections and their ease in consumption & adherence. Increase in the number of HIV infected patients across the globe increases the need for effective treatment for HIV related diseases. Use of Multi-class combination products is an efficient way of treating HIV. Atripla and Prezista are among the blockbuster combination drugs used in the HIV treatment.
North America was the highest revenue contributor in 2015; this is attributed to the awareness about healthcare in the region, higher HIV diagnosis & treatment rate, ample healthcare expenditure, well-established healthcare system, and proactive government initiatives to control the spread of HIV in the North American countries. Gilead, GlaxoSmithKline, Novartis, and Merck & Co. are some of the key players in the North American HIV drugs market. However, Asia-Pacific region is projected to grow with the highest CAGR of 6.3% during the analysis period, due to the presence large HIV patient pool and ample growth opportunities in terms of unmet medical needs for management of HIV in the region. Moreover, increase in focus & investment from leading players in the region support the growth of the HIV drugs market in the Asia-Pacific region.
Key findings of HIV Drug Market
In 2015, multi-class combination drugs segment was the leading medication class segment.
The branded drug Triumeq of multi-class combination drug segment is estimated to grow at the CAGR of 20.7%.
North America market is projected to grow at a CAGR of 3.4% during analysis period.
The Nucleoside Reverse Transcriptase Inhibitors (NRTIs) segment is estimated to grow at the CAGR of 0.4%.
The major companies profiled in the report include Boehringer Ingelheim International GmbH, Merck & Co., Inc., ViiV Healthcare, AbbVie, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, Gilead Sciences, Inc., Johnson & Johnson, and Cipla Limited.
Connect to Analyst: https://www.alliedmarketresearch.com/connect-to-analyst/1867
Allied Market Research is a Market Research Company which offers Syndicate & Custom Market Research Reports with Consulting Services
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
United States.
Int'l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
help@alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HIV Drug Market to Reach $26,458 Million, Globally by 2022 here
News-ID: 446210 • Views: …
More Releases from Allied Market Research
Aviation Gasoline Market Growth, Competitive Analysis, Prospects, And Top Key Pl …
The aviation gasoline market is characterized by a delicate balance between technological innovation, regulatory compliance, and market demand. As aircraft manufacturers continue to develop more efficient and environmentally friendly piston engines, the demand for advanced formulations of avgas evolves accordingly. Moreover, stringent safety and quality standards imposed by aviation authorities worldwide shape the production, distribution, and usage of avgas.
The global aviation gasoline (avgas) market size was valued at $12.5 billion…
Uninterrupted Power Supply (UPS) System Market Detailed Insights 2020-2027 | Key …
The global uninterrupted power supply market was valued at $7.4 billion in 2019, and is projected to reach $9.4 billion by 2027, growing at a CAGR of 4.3% from 2020 to 2027.
UPS provide emergency power protection connected loads during any type of power failure. The uninterrupted power supply (UPS) system provide battery back up whenever there is any interruption in power flow. In addition, it also protects the system from…
Green Carbon Market Outlook: Experts Forecast Unprecedented Growth & Opportuniti …
According to the report, the global green carbon industry's value was $16.8 million in 2025 and is projected to reach $32.9 million by 2031, with a Compound Annual Growth Rate (CAGR) of 11.9% from 2022 to 2031. The report provides an in-depth analysis of market trends, key segments, investment opportunities, value chain, regional landscape, and competitive scenario.
Want to Access the Statistical Data and Graphs, Key Players' Strategies: https://www.alliedmarketresearch.com/green-carbon-market/purchase-options
Drivers, Restraints,…
Transmission Sales Market to Witness an Outstanding Growth during 2020-2030 | Hi …
Pressurizing and accumulation of the gas inside a pipeline by giving efficient processing to the gas for control and safety systems, maintain correct pressure levels, recovering and recompressing the processed gas, processing biogas derived from water and residential waste and avoiding contamination of the processed gas is done by a transmission sales. Pressurizing and accumulation of the gas inside pipelines is done by giving efficient processing to the gas…
More Releases for HIV
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments
Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV…
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Introduction to Human Immunodeficiency Virus (HIV) Vaccines
1.1 Overview
1.2 Antiquity of HIV Vaccine
Need for the Development of HIV Vaccine
Primer of HIV inside the Body
3.1 Inclusion of HIV Virus into the System
3.2 Interaction of HIV with Host
3.3 Eradication of HIV Virus
HIV Vaccine Development Process
4.1 Introduction
…
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways…
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus.
Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral…
